RE:RE:RE:RE:A Catalyst New Event
Now that GOBLET is so awesome
Almost forgot abou the other pancreatic trial Phase 2 NU 18I01
Pembrolizumab/ Keytruda (anti-PD1 mAb)
Phase 2 NU 18I01:
https://www.streetwisereports.com/article/2021/08/18/biotech-offering-significant-return-potential-advances-lead-breast-cancer-trials.html
This trial results could come out soon. Again this was totally discouted but new buzz can come back.